首页> Cancer research communications> Targeting Tumor Angiogenesis with the Selective VEGFR-3 Inhibitor EVT801 in Combination with Cancer Immunotherapy.

Targeting Tumor Angiogenesis with the Selective VEGFR-3 Inhibitor EVT801 in Combination with Cancer Immunotherapy.

导出 LinkOut

翻译打印收藏纠错

第一作者： Michael R,Paillasse

第一单位： Evotec France, Campus Curie, Toulouse CEDEX, France.

作者： Michael R,Paillasse ^[1] ; Michael,Esquerré ^[1] ; Florie A,Bertrand ^[1] ; Céline,Poussereau-Pomié ^[1] ; Mélanie,Pichery ^[1] ; Virgile,Visentin ^[1] ; Geneviève,Gueguen-Dorbes ^[1] ; Florence,Gaujarengues ^[1] ; Pauline,Barron ^[1] ; Gaelle,Badet ^[1] ; Anne,Briaux ^[1] ; Pierre-Benoit,Ancey ^[1] ; David,Sibrac ^[1] ; Eric,Erdociain ^[1] ; Dennis,Özcelik ^[2] ; Jérôme,Meneyrol ^[1] ; Valérie,Martin ^[3] ; Anne,Gomez-Brouchet ^[4] ; Janik,Selves ^[4] ; Philippe,Rochaix ^[4] ; Maxime,Battistella ^[5] ; Céleste,Lebbé ^[6] ; Jean-Pierre,Delord ^[4] ; Frédérique,Dol-Gleizes ^[1] ; Françoise,Bono ^[1] ; Isabelle,Blanc ^[1] ; Antoine,Alam ^[7] ; Ian,Hunneyball ^[8] ; Mark,Whittaker ^[8] ; Pierre,Fons ^[1]

作者单位： Evotec France, Campus Curie, Toulouse CEDEX, France. ^[1] Evotec SE, Manfred Eigen Campus, Hamburg, Germany. ^[2] Sanofi, Chilly-Mazarin, France. ^[3] Institut Universitaire du Cancer Toulouse Oncopole (IUCT-O), Toulouse, Occitanie, France. ^[4] Université de Paris, Department of Pathology, AP-HP Hôpital Saint Louis, INSERM U976, Paris, France. ^[5] Université de Paris, Department of Dermatology, AP-HP Hôpital Saint Louis, INSERM U976, Paris, France. ^[6] Evotec ID, Lyon, France. ^[7] Evotec Ltd, Oxfordshire, United Kingdom. ^[8]

医学主题词人类(Humans);小鼠(Mice);动物(Animals);血管内皮生长因子受体3(Vascular Endothelial Growth Factor Receptor-3);新生血管化, 病理性(Neovascularization, Pathologic);肿瘤(Neoplasms);血管生成抑制剂(Angiogenesis Inhibitors);蛋白激酶抑制剂(Protein Kinase Inhibitors);免疫疗法(Immunotherapy);肿瘤微环境(Tumor Microenvironment)

DOI 10.1158/2767-9764.CRC-22-0151

PMID 36970050

发布时间 2023-07-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cancer research communications

2022年2卷11期

1504-1519页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Cancer research communications

2022年2卷11期

1504-1519页

检索历史清除

Targeting Tumor Angiogenesis with the Selective VEGFR-3 Inhibitor EVT801 in Combination with Cancer Immunotherapy.

Cancer research communications

相似文献

同项目论文

Cancer research communications

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Targeting Tumor Angiogenesis with the Selective VEGFR-3 Inhibitor EVT801 in Combination with Cancer Immunotherapy.

Cancer research communications

相似文献

同项目论文

Cancer research communications

相关期刊

检索历史清除